Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOCETAXEL vs DOCETAXEL ANHYDROUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOCETAXEL vs DOCETAXEL ANHYDROUS: Safety Overview

Metric DOCETAXEL DOCETAXEL ANHYDROUS
Total FAERS Reports 64,992 1,084
Deaths Reported 6,068 5
Death Rate 9.3% 0.5%
Hospitalizations 13,463 10
Average Patient Age 56.0 yrs 55.6 yrs
% Female Patients 83.4% 99.2%
FDA Approval Date Apr 1, 2019 N/A
Manufacturer Mylan Institutional LLC Mylan Institutional LLC
Route INTRAVENOUS INTRAVENOUS
Marketing Status Discontinued N/A